SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge
Eisenmenger’s syndrome (ES) is the most severe phenotype of pulmonary arterial hypertension (PAH) secondary to congenital heart disease. In these cases, a significant systemic-to-pulmonary (left-to-right) shunting triggers the development of pulmonary vascular disease (PVD) and pulmonary hypertensi...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2023-11-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/2741 |
_version_ | 1797635625487171584 |
---|---|
author | Paola Pierucci Lucrezia De Michele Maria Luisa de Candia Federica Barratta Cesare Gregoretti Giovanna Elisiana Carpagnano Giovanni Misseri |
author_facet | Paola Pierucci Lucrezia De Michele Maria Luisa de Candia Federica Barratta Cesare Gregoretti Giovanna Elisiana Carpagnano Giovanni Misseri |
author_sort | Paola Pierucci |
collection | DOAJ |
description |
Eisenmenger’s syndrome (ES) is the most severe phenotype of pulmonary arterial hypertension (PAH) secondary to congenital heart disease. In these cases, a significant systemic-to-pulmonary (left-to-right) shunting triggers the development of pulmonary vascular disease (PVD) and pulmonary hypertension. In cases of acute hypoxemic respiratory failure in patients with ES, high flow nasal cannula (HFNC) oxygen therapy should be considered as a first-line approach in order to avoid pulmonary complications and right ventricular overload related to positive pressure ventilation. Here, we report a case of HFNC use in a patient with COVID-19 infection and ES.
|
first_indexed | 2024-03-11T12:23:04Z |
format | Article |
id | doaj.art-c45dd57fabc84cbd921e0af8294ad8d2 |
institution | Directory Open Access Journal |
issn | 1122-0643 2532-5264 |
language | English |
last_indexed | 2024-03-11T12:23:04Z |
publishDate | 2023-11-01 |
publisher | PAGEPress Publications |
record_format | Article |
series | Monaldi Archives for Chest Disease |
spelling | doaj.art-c45dd57fabc84cbd921e0af8294ad8d22023-11-06T19:02:36ZengPAGEPress PublicationsMonaldi Archives for Chest Disease1122-06432532-52642023-11-0110.4081/monaldi.2023.2741SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challengePaola Pierucci0Lucrezia De Michele1Maria Luisa de Candia2Federica Barratta3Cesare Gregoretti4Giovanna Elisiana Carpagnano5Giovanni Misseri6Cardiothoracic Department, Respiratory and Critical Care Unit, Bari Policlinic University Hospital, Bari; Section of Respiratory Diseases, Department of Basic Medical Science Neuroscience and Sense Organs, University of Bari “Aldo Moro”Cardio Thoracic and Vascular Department, Cardiology Unit, Bari Policlinic University Hospital, BariCardiothoracic Department, Respiratory and Critical Care Unit, Bari Policlinic University Hospital, Bari; Section of Respiratory Diseases, Department of Basic Medical Science Neuroscience and Sense Organs, University of Bari “Aldo Moro”Cardiothoracic Department, Respiratory and Critical Care Unit, Bari Policlinic University Hospital, Bari; Section of Respiratory Diseases, Department of Basic Medical Science Neuroscience and Sense Organs, University of Bari “Aldo Moro”Department of Surgical, Oncological and Oral Science, University of Palermo; Fondazione Istituto “G. Giglio” Cefalù (PA) Cardiothoracic Department, Respiratory and Critical Care Unit, Bari Policlinic University Hospital, Bari; Section of Respiratory Diseases, Department of Basic Medical Science Neuroscience and Sense Organs, University of Bari “Aldo Moro”Fondazione Istituto “G. Giglio” Cefalù (PA) Eisenmenger’s syndrome (ES) is the most severe phenotype of pulmonary arterial hypertension (PAH) secondary to congenital heart disease. In these cases, a significant systemic-to-pulmonary (left-to-right) shunting triggers the development of pulmonary vascular disease (PVD) and pulmonary hypertension. In cases of acute hypoxemic respiratory failure in patients with ES, high flow nasal cannula (HFNC) oxygen therapy should be considered as a first-line approach in order to avoid pulmonary complications and right ventricular overload related to positive pressure ventilation. Here, we report a case of HFNC use in a patient with COVID-19 infection and ES. https://www.monaldi-archives.org/index.php/macd/article/view/2741pulmonary hypertensionHFNCCOVID-19noninvasive ventilationintensive care |
spellingShingle | Paola Pierucci Lucrezia De Michele Maria Luisa de Candia Federica Barratta Cesare Gregoretti Giovanna Elisiana Carpagnano Giovanni Misseri SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge Monaldi Archives for Chest Disease pulmonary hypertension HFNC COVID-19 noninvasive ventilation intensive care |
title | SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge |
title_full | SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge |
title_fullStr | SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge |
title_full_unstemmed | SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge |
title_short | SARS-CoV-2 pneumonia and Eisenmenger’s Syndrome: doubling the challenge |
title_sort | sars cov 2 pneumonia and eisenmenger s syndrome doubling the challenge |
topic | pulmonary hypertension HFNC COVID-19 noninvasive ventilation intensive care |
url | https://www.monaldi-archives.org/index.php/macd/article/view/2741 |
work_keys_str_mv | AT paolapierucci sarscov2pneumoniaandeisenmengerssyndromedoublingthechallenge AT lucreziademichele sarscov2pneumoniaandeisenmengerssyndromedoublingthechallenge AT marialuisadecandia sarscov2pneumoniaandeisenmengerssyndromedoublingthechallenge AT federicabarratta sarscov2pneumoniaandeisenmengerssyndromedoublingthechallenge AT cesaregregoretti sarscov2pneumoniaandeisenmengerssyndromedoublingthechallenge AT giovannaelisianacarpagnano sarscov2pneumoniaandeisenmengerssyndromedoublingthechallenge AT giovannimisseri sarscov2pneumoniaandeisenmengerssyndromedoublingthechallenge |